[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
April 2006

Interferon Beta-1a Treatment and African Americans

Arch Neurol. 2006;63(4):627-628. doi:10.1001/archneur.63.4.627-c

In the article “Response to Interferon Beta-1a Treatment in African American Multiple Sclerosis Patients,” the authors1 suggest that African Americans (AAs) are less responsive to interferon beta-1a than white Americans (WAs), paralleling an earlier publication2 that showed a more rapid progression of multiple sclerosis in AA patients. Their conclusions have implications for further study, but their data raise several questions.

First Page Preview View Large
First page PDF preview
First page PDF preview